<DOC>
	<DOC>NCT01574430</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of PDT at 30% verteporfin dose in the treatment of CSC.</brief_summary>
	<brief_title>Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)</brief_title>
	<detailed_description />
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<mesh_term>Verteporfin</mesh_term>
	<criteria>patients with CSC patients signed the ICF patients with course of CSC less than 6 months patients did not undertake any treatment for CSC patients with porphyria patients allergic to verteporfin pregnant or nursing women poor patients compliance sever liver dysfunction dioptric media opacities which make it difficult to exam fundus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>